Congress Needs To Review “Authorized” Generics, Hatch And Waxman Agree
Executive Summary
Congress will likely have to look at the issue of "authorized" generics, Sen. Orrin Hatch (R-Utah) and Rep. Henry Waxman (D-Calif.) said during an Oct. 6 Drug & Device Dialogue audio conference sponsored by FDC Reports and Polidais LLC
You may also be interested in...
FTC Should Study Competitive Impact Of “Authorized” Generics, Senators Say
A bipartisan group of senators is asking the Federal Trade Commission to study the competitive impact of "authorized" generics
FTC Should Study Competitive Impact Of “Authorized” Generics, Senators Say
A bipartisan group of senators is asking the Federal Trade Commission to study the competitive impact of "authorized" generics
“Authorized” Generics Will Be Subject To “Best Price” Calculations – CMS
The Centers for Medicare & Medicaid Services is indicating that it will consider "authorized" generics to be brand drugs for the purposes of best price reporting